Myomo, Inc.
One Broadway, 14th Floor
Cambridge
Massachusetts
02142
United States
Tel: 617-996-9058
Fax: 617-886-0333
Website: http://www.myomo.com/
154 articles about Myomo, Inc.
-
Myomo to Report Third Quarter 2021 Financial Results on November 10, 2021
11/3/2021
Myomo, Inc. today announced that it will report financial results for the three and nine months ended September 30, 2021 on November 10, 2021 after the market close.
-
Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants
10/15/2021
Myomo, Inc. today announced it has entered into agreements with certain of its holders of its existing 2020 investor warrants exercisable for 1,015,798 shares of its common stock, in the aggregate, pursuant to which such holders agreed to exercise their warrants for cash at an exercise price of $5.00 per share.
-
Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders
8/9/2021
Myomo, Inc. today announced financial results for the three and six months ended June 30, 2021.
-
Myomo, Inc. Announces Participation in A.G.P.’s Virtual MedTech Summer Conference on July 29, 2021
7/23/2021
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021.
-
Myomo, Inc. Stock Added to Russell Microcap® Index
6/28/2021
Myomo, Inc. Stock Added to Russell Microcap ® Index
-
Myomo to Present at Sidoti Virtual Investor Conference on June 23, 2021
6/16/2021
Myomo, Inc.today announced that Paul R. Gudonis, Chief Executive Officer, and David Henry, Chief Financial Officer, will present a corporate overview of the company at the Sidoti Virtual Investor Conference on Wednesday, June 23, 2021.
-
Myomo Shareholders Elect Dr. Milton Morris as Director
6/14/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that its shareholders, at its meeting on June 9, 2021, elected Milton Morris, PhD, as Director.
-
Myomo Provides Update on CMS Discussions
6/8/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, provided an update regarding its application for a Healthcare Common Procedure Coding System Level II code change and benefit category redetermination for HCPCS codes L8701 and L8702 submitted in January 2021.
-
Myomo to Present at the Summer Solstice - Best Ideas From the Buy Side Conference
5/27/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that CEO Paul R. Gudonis and CFO David Henry will present at the Summer Solstice – Best Ideas From the Buy Side Conference on June 1, 2021 at 2:30 p.m. Eastern time.
-
Myomo Reports First Quarter 2021 Financial Results
5/5/2021
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2021.
-
Myomo to Report First Quarter 2021 Financial Results on May 5, 2021
4/27/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that it will report financial results for the three months ended March 31, 2021 on May 5, 2021 after the market close.
-
Myomo Participates in Ground-breaking Brain-computer Interface Trial
4/1/2021
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Thomas Jefferson University of Philadelphia has successfully completed the first phase of clinical trials
-
Myomo Reports Fourth Quarter and Full Year 2020 Financial Results
3/10/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced financial results for the three months and year ended December 31, 2020.
-
Myomo to Participate in Three Investment Conferences During the Month of March 2021
3/4/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that Paul R.
-
Myomo to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021
3/4/2021
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months and year ended December 31, 2020 on March 10, 2021 after the market close.
-
Germany's Largest Statutory Health Insurance Company Approves MyoPro
2/16/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced Techniker Krankenkasse, Germany's largest Statutory Health Insurance company, now approves reimbursement of MyoPro on a case-by-case basis.
-
Myomo to Present at the Winter Wonderland – Best Ideas from the Buy-side Conference
2/12/2021
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will present at the Winter Wonderland – Best Ideas from the Buy-side Conference. The conference is being held virtually on February 16 th through February 19 th .
-
Myomo® Forms Joint Venture to Manufacture and Sell the Company’s Products in China
1/26/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces the signing of a definitive agreement with Beijing Ryzur Medical Investment Co., Ltd. to form a joint venture to manufacture and sell the Company’s current and future products in greater China, including Hong Kong, Macau and Taiwan.
-
Myomo Reports Preliminary Fourth Quarter and Full Year 2020 Results
1/11/2021
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2020.
-
Myomo to Present at Sidoti & Company Virtual Microcap Conference
11/18/2020
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be presenting at the Sidoti & Company Virtual Microcap Conference on Thursday, November 19, 2020 at 1:45 p.m. Eastern Time. The presentation will be webcast live and av